ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,168.00
      0.52%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.275
      0.00%
      Bitcoin
      66,238.99
      0.07%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started

        GILD

        DMG Mori (GILD)

        		Date:
        Sort by:
         Showing the most relevant articles for your search:NASDAQ:GILD
        DateTimeSourceHeadlineSymbolCompany
        12/22/20112:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GILDGilead Sciences Inc
        12/22/20112:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GILDGilead Sciences Inc
        12/21/20116:45AMZacksGilead's Candidate under EMA Review - Analyst BlogNASDAQ:GILDGilead Sciences Inc
        12/20/20117:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GILDGilead Sciences Inc
        12/20/20114:30PMBusiness WireGilead Files European Marketing Application for the Quad, a Once-Daily Single-Tablet Regimen for the Treatment of HIV InfectionNASDAQ:GILDGilead Sciences Inc
        12/19/20117:30AMMarketwiredCoronado Biosciences to Begin Trading on NASDAQ TodayNASDAQ:GILDGilead Sciences Inc
        12/16/20113:07PMDow Jones News3rd UPDATE: Pharmasset Halts Hepatitis C Drug In Mid-Stage TrialNASDAQ:GILDGilead Sciences Inc
        12/16/201111:05AMDow Jones News2nd UPDATE: Pharmasset Halts Hepatitis C Drug In Mid-Stage TrialNASDAQ:GILDGilead Sciences Inc
        12/16/201110:14AMDow Jones NewsUPDATE: Pharmasset Halts Hepatitis C Drug In Mid-Stage TrialNASDAQ:GILDGilead Sciences Inc
        12/16/20119:06AMDow Jones NewsPharmasset To Change Design Of Hepatitis C Treatment StudyNASDAQ:GILDGilead Sciences Inc
        12/15/20114:30PMBusiness WireGilead Sciences Submits Supplemental New Drug Application to U.S. Food & Drug Administration for Truvada® for Reducing the R...NASDAQ:GILDGilead Sciences Inc
        12/13/20114:38PMDow Jones NewsUPDATE: European Agency Recommends Recall Of Gilead's VistideNASDAQ:GILDGilead Sciences Inc
        12/13/20111:04PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:GILDGilead Sciences Inc
        12/12/20114:45AMZacksGilead Presents Elvitegravir Data - Analyst BlogNASDAQ:GILDGilead Sciences Inc
        12/09/20118:30AMBusiness WireGilead Announces Two-Year Data From Pivotal Phase 3 Study of Elvitegravir, an Integrase Inhibitor for HIVNASDAQ:GILDGilead Sciences Inc
        12/08/20113:00PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:GILDGilead Sciences Inc
        12/08/201111:27AMDow Jones NewsUS Bond Markets Expecting Only Smaller Issues To PriceNASDAQ:GILDGilead Sciences Inc
        12/08/20116:39AMBusiness WireGilead Sciences and World Health Organization Establish New Five-Year Initiative to Prevent Deaths from Visceral LeishmaniasisNASDAQ:GILDGilead Sciences Inc
        12/08/20116:09AMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:GILDGilead Sciences Inc
        12/07/20116:12PMDow Jones NewsUS Bond Market Issuance Is Subdued In Active Secondary TradingNASDAQ:GILDGilead Sciences Inc
        12/07/20115:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GILDGilead Sciences Inc
        12/07/201110:06AMDow Jones NewsCorporate-Bond Issuance Slowing, As Backdrop Remains FavorableNASDAQ:GILDGilead Sciences Inc
        12/07/20116:03AMEdgar (US Regulatory)Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)NASDAQ:GILDGilead Sciences Inc
        12/07/20113:30AMZacksThe Zacks Analyst Blog Highlights: AutoZone, Johnson & Johnson, Bristol-Myers Squibb, Gilead Sciences & Pharmasset - Press Re...NASDAQ:GILDGilead Sciences Inc
        12/06/20116:13PMBusiness WireGilead Prices $3.7 Billion of Senior Unsecured NotesNASDAQ:GILDGilead Sciences Inc
        12/06/20115:38PMDow Jones NewsUPDATE: Gilead Sciences Sells $3.7 Billion Bond Issue TuesdayNASDAQ:GILDGilead Sciences Inc
        12/06/20115:11PMDow Jones NewsStable Backdrop Prompts Issuers To Rush US Bond Market, AgainNASDAQ:GILDGilead Sciences Inc
        12/06/20113:04PMDow Jones NewsGilead Sciences Marketing $3.7 Billion Bond Issue Tuesday - SourceNASDAQ:GILDGilead Sciences Inc
        12/06/20119:52AMDow Jones NewsGilead Sciences Issuing 4-Part Benchmark-Size Deal Tuesday -SourceNASDAQ:GILDGilead Sciences Inc
        12/06/20119:15AMZacksGilead Delivers Once Again - Analyst BlogNASDAQ:GILDGilead Sciences Inc
         Showing the most relevant articles for your search:NASDAQ:GILD